FDA recall, , Moderate risk
Gulf Coast Regional Blood Center Red Blood Cells and Pooled Cryoprecipitated AHF
Red blood cells and pooled cryoprecipitated AHF may have been prepared incorrectly.
Recall ended Jun 8, 2026. Still check yours.
What happened
Gulf Coast Regional Blood Center began a recall on July 17, 2025, of Pooled Cryoprecipitated AHF, Red Blood Cells, Leukocytes Reduced, and Apheresis Red Blood Cells, Leukocytes Reduced, because arm preparation may have been performed incorrectly. The products were distributed in California and Texas. The FDA added the recall to its Enforcement Report and classified it on June 8, 2026.
2 photos
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
3 products
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Reason: Red Blood Cells, Leukocytes Reduced, for which arm preparation may have been performed incorrectly, were distributed.
Pooled Cryoprecipitated AHF
Reason: Pooled Cryoprecipitated AHF, for which arm preparation may have been performed incorrectly, were distributed.
Apheresis Red Blood Cells, Leukocytes Reduced
Reason: Apheresis Red Blood Cells, Leukocytes Reduced, for which arm preparation may have been performed incorrectly, were distributed.
Recall details
- Company began the recall
- Sold in
- Company
- Gulf Coast Regional Blood Center
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98749
- Recall numbers
- B-0067-2026 to B-0069-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived



